SECOND BIOLOGICAL DMARD THERAPY IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE COHORT ANALYSIS

被引：0
|
作者：
Saadaoui, K. [1 ]
Sahli, H. [1 ]
Jemmali, S. [1 ]
Boussaid, S. [1 ]
Rekik, S. [1 ]
Cheour, E. [1 ]
Elleuch, M. [1 ]
机构：
[1] La Rabta Hosp, Rheumatol, Tunis, Tunisia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.3871
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0238
引用
收藏
页码：1144 / 1145
页数：2
相关论文
共 50 条
  • [1] Drug survival of second biological DMARD therapy in patients with rheumatoid arthritis: a retrospective non-interventional cohort analysis
    Wilke, Thomas
    Mueller, Sabrina
    Lee, Sze Chim
    Majer, Istvan
    Heisen, Marieke
    BMC MUSCULOSKELETAL DISORDERS, 2017, 18
  • [2] Drug survival of second biological DMARD therapy in patients with rheumatoid arthritis: a retrospective non-interventional cohort analysis
    Thomas Wilke
    Sabrina Mueller
    Sze Chim Lee
    Istvan Majer
    Marieke Heisen
    BMC Musculoskeletal Disorders, 18
  • [3] Patterns of Change of a Second Biological Dmard in a Cohort of Patients with Rheumatoid Arthritis
    Rolon Campuzano, Roger
    Coronel Ale, Andrea Lujan
    Cerda, Osvaldo
    Dal Pra, Fernando
    Schneeberger, Emilce E.
    de los Angeles Correa, Maria
    Rosemffet, Marcos G.
    Buschiazzo, Emilio
    Garcia Salinas, Rodrigo
    Beatriz Papasidero, Silvia
    Barrios, Belen
    Maldonado Ficco, Hernan
    Citera, Gustavo
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] PATTERNS OF CHANGE OFA SECOND BIOLOGICAL DMARD IN A COHORT OF RHEUMATOID ARTHRITIS PATIENTS
    Rolon Campuzano, R.
    Coronel Ale, A. L.
    Cerda, O. L.
    Dal Pra, F.
    Schneeberger, E. E.
    Correa, M. A.
    Rosemffet, M. G.
    Buschiazzo, E.
    Garcia Salinas, R.
    Papasidero, S. B.
    Barrios, B. I.
    Maldonado, Ficco H.
    Citera, G.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S4 - S4
  • [5] The efficacy and safety of bucillamine as a second-line DMARD in the treatment of rheumatoid arthritis: a retrospective cohort study
    Suda, Akiko
    Nagaoka, Shouhei
    Ohono, Shigeru
    Ideguchi, Haruko
    Soga, Takayoshi
    Ishigatsubo, Yoshiaki
    MODERN RHEUMATOLOGY, 2008, 18 (06) : 609 - 614
  • [6] SURVIVAL OF SYNTHETIC AND BIOLOGICAL DMARD THERAPY IN RHEUMATOID ARTHRITIS: RESULTS OF DAILY CLINICAL PRACTICE
    Rojas-Zuleta, W. G.
    Pantoja-Marquez, A. E.
    Vasquez, M.
    Duque-Zapata, N.
    Orozco, C.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S75 - S75
  • [7] Second-line therapy with biological drugs in rheumatoid arthritis patients in German rheumatologist practices: a retrospective database analysis
    Nina Gossen
    Louis Jacob
    Karel Kostev
    Rheumatology International, 2016, 36 : 1113 - 1118
  • [8] Second-line therapy with biological drugs in rheumatoid arthritis patients in German rheumatologist practices: a retrospective database analysis
    Gossen, Nina
    Jacob, Louis
    Kostev, Karel
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (08) : 1113 - 1118
  • [9] Combination DMARD therapy for rheumatoid arthritis. Full or low DMARD doses?
    Ferraccioli, GF
    Casatta, L
    DiPoi, E
    Damato, R
    Bartoli, E
    ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (05) : 336 - 337
  • [10] Selection of DMARD therapy in early rheumatoid arthritis.
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S269 - S269
12345